UNSPSC 51122800: Antiarrythmic alcohols

This classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC ALCOHOLS.

UNSPSC 51122800 Antiarrhythmic alcohols, a Class code, covers emergency cardiac medications and related pharmaceutical products that state and local governments purchase for emergency medical services, hospital systems, and health agency operations. State and local buyers source specific antiarrhythmic drugs—including adenosine, diltiazem, labetalol, and epinephrine formulations—through formal competitive procurements with firm pricing, quality warranties covering minimum expiration horizons, and logistics requirements including rapid fulfillment and expired-stock replacement. Issuing bodies span city fire departments, state health agencies, and multistate cooperative purchasing alliances; the City of Tampa's fire rescue, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent recent activity across municipal emergency services and state-level pharmacy benefit programs.

The code sees recent activity across Florida, Texas, and Minnesota. The City of Tampa Purchasing Department issued an IFB (Bid No. 26-P-00188) on April 24, 2026, with a response deadline of April 8, 2026, for Advanced Life Support Medications including 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000.00 and a one-year term plus two optional one-year renewals. The Texas HHS Commission posted a Request for Information (RFI No. HHS0017013) on April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs and pharmacy benefit optimization, signaling state-level strategic procurement planning. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring manufacturer compliance with Good Manufacturing Practices, Drug Supply Chain Security Act certification, and authorized wholesaler relationships, with contract effectiveness set for July 1, 2026. Municipal fire-rescue operations and state pharmacy programs dominate the recent opportunity set.